Related Experiment Videos
Non-AIDS-defining cancers
1Department of Medicine, Ireland Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA.
Hematology/Oncology Clinics of North America
|October 1, 1996
Summary
The spectrum of cancers in patients with acquired immunodeficiency syndrome (AIDS) is broadening. Increased incidence of non-AIDS-defining cancers in HIV-infected individuals suggests viral infections may drive oncogenesis.
Area of Science:
- Oncology
- Infectious Diseases
- Epidemiology
Background:
- The acquired immunodeficiency syndrome (AIDS) epidemic continues to evolve.
- HIV-infected individuals exhibit an increasing range of malignancies.
- Several non-AIDS-defining cancers are observed with greater frequency in this population.
Purpose of the Study:
- To document the expanding spectrum of malignancies in the context of the advancing AIDS epidemic.
- To identify specific non-AIDS-defining cancers with increased incidence in HIV-infected patients.
- To explore the potential role of concurrent viral infections in the pathogenesis of these neoplasms.
Main Methods:
- Epidemiological tracking of cancer incidence in HIV-infected patients.
- Review of clinical and biological features of non-AIDS-defining cancers.
- Investigation into the association between viral infections and oncogenesis in the HIV-infected host.
Main Results:
- An expanding spectrum of malignancies is noted in patients with acquired immunodeficiency syndrome (AIDS).
- Specific non-AIDS-defining cancers, including basal cell carcinoma, anal squamous cell carcinoma, Hodgkin's disease, seminoma, and pediatric leiomyosarcoma, show increased incidence.
- Concurrent viral infections are implicated in the pathogenesis of AIDS-related neoplasms.
Conclusions:
- The rising incidence of non-AIDS-defining cancers in HIV-infected patients warrants close monitoring.
- Concurrent viral infections likely play a significant role in the development of these cancers.
- Further research in this area may yield broader insights into malignant transformation and oncogenesis.